Welcome to our dedicated page for TransUnion SEC filings (Ticker: TRU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransUnion filings document the public-company disclosures of a credit reporting, consumer information, fraud detection, marketing, and analytics provider. Recent Form 8-K reports cover quarterly operating results, Regulation FD presentations, Investor Day materials, and management discussions of the company’s proprietary data foundation, OneTru technology platform, and Credit, Marketing, Fraud, and Consumer Solutions.
The company’s SEC record also includes proxy materials for annual meeting matters, director elections, board committee assignments, executive compensation, and governance practices. Other filings document material agreements, credit facility amendments, revolving credit commitments, guarantees, collateral arrangements, capital structure, and board composition changes.
TransUnion executive Todd C. Skinner, President, International, reported a small automatic stock sale. On 02/02/2026, he sold 500 shares of TransUnion common stock at a price of $78.79 per share under a pre-arranged Rule 10b5-1 trading plan. After this transaction, he beneficially owned 31,724.727 shares directly.
Todd Skinner has filed a notice of proposed sale of TRU stock under Rule 144. The filing covers 500 shares of common stock to be sold through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $39,395 and 194,200,000 shares outstanding. The approximate sale date is February 2, 2026. The 500 shares come from an employee stock purchase on June 30, 2025 (114 shares bought for cash) and 386 restricted shares that vested on August 25, 2025 as compensation. In the past three months, Skinner sold 500 shares on December 10, 2025 for $40,535 and another 500 shares on January 2, 2026 for $42,855.
Massachusetts Financial Services Company reports beneficial ownership of 15,540,471 shares of TransUnion common stock, representing 8.0% of the outstanding class as of the relevant date. MFS has sole voting power over 15,170,635 shares and sole dispositive power over 15,540,471 shares.
MFS states the shares were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing control of TransUnion or participating in any control-related transactions.
TransUnion director Charlotte Yarkoni reported a new equity award. On January 5, 2026, she received a grant of 836 shares of TransUnion common stock at a price of $0 per share. This reflects a restricted stock award tied to her service on the Board of Directors.
The 836 restricted shares will vest on May 7, 2026, meaning they become fully owned by her on that date if the vesting conditions are met. Following this grant, she beneficially owns 836 TransUnion shares directly.
TransUnion director Sayan Chakraborty reported an equity award of company stock. On January 5, 2026, he received a grant of 836 shares of common stock, reported at a price of $0 per share, reflecting a restricted stock award rather than an open-market purchase. According to the footnote, these restricted shares were granted in connection with his appointment to the Board of Directors and are scheduled to vest on May 7, 2026. Following this grant, he beneficially owns 836 TransUnion shares, held directly.
TransUnion director files initial ownership report with no holdings
TransUnion director Charlotte Yarkoni filed an initial ownership report covering an event date of 01/05/2026. The filing shows she serves as a director of TransUnion but does not beneficially own any TransUnion securities, as it explicitly states that no securities are beneficially owned.
TransUnion director reports no beneficial ownership on Form 3
TransUnion director Sayan Chakraborty filed an initial ownership report stating that no TransUnion securities are beneficially owned. The filing confirms Chakraborty’s role as a director and indicates that there are no non-derivative or derivative securities reported as directly or indirectly held. This is an administrative disclosure required for insiders and does not describe any stock transactions or option grants.
TransUnion's President, International reported a small insider stock sale under a pre-arranged Rule 10b5-1 trading plan. On 01/02/2026, the officer sold 500 shares of TransUnion common stock at a price of $85.71 per share. After this transaction, the officer beneficially owns 32,224.727 shares of common stock. This ownership amount includes 72.708 shares acquired through the company’s employee stock purchase plan since the officer’s prior report.
TransUnion reported an insider stock sale by a senior officer. On 01/02/2026, an officer serving as President, US Markets sold 1,000 shares of TransUnion common stock at a price of $85.71 per share in an open market transaction.
The filing states that this sale was made under a pre-arranged Rule 10b5-1 trading plan, which is designed to allow insiders to trade shares according to a set schedule. After this transaction, the officer beneficially owned 61,592 shares of TransUnion common stock.
A shareholder of TransUnion filed a notice to sell 500 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of $42,855.00. The shares to be sold come from 413 shares acquired through restricted stock vesting on 02/25/2025 as compensation and 87 shares purchased under an employee stock purchase plan on 06/30/2025 for cash. Over the prior three months, the same shareholder, Todd Skinner, sold 500 common shares on 12/10/2025 for gross proceeds of $40,535.00. By signing the notice, the shareholder represents that he is not aware of any undisclosed material adverse information about TransUnion.